1995
DOI: 10.1016/s0261-5614(95)80016-6
|View full text |Cite
|
Sign up to set email alerts
|

Factors influencing the stability of ranitidine in TPN mixtures

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

1996
1996
2023
2023

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 12 publications
(2 citation statements)
references
References 9 publications
0
2
0
Order By: Relevance
“…Weinberg and Bell produced the first tissue‐engineered blood vessel using endothelial cells (ECs) and smooth muscle cells (SMCs) in gelatin (12). Since then, various approaches to culturing vascular grafts composed of ECs and SMCs have been developed (13–17). In the process, autologous vessels must be harvested to isolate ECs and SMCs.…”
mentioning
confidence: 99%
“…Weinberg and Bell produced the first tissue‐engineered blood vessel using endothelial cells (ECs) and smooth muscle cells (SMCs) in gelatin (12). Since then, various approaches to culturing vascular grafts composed of ECs and SMCs have been developed (13–17). In the process, autologous vessels must be harvested to isolate ECs and SMCs.…”
mentioning
confidence: 99%
“…Alternatively, if a patient is receiving parenteral nutrition, cimetidine, ranitidine, and famotidine are stable in total nutrient admixtures for 24 hours at room temperature. [169][170][171][172][173][174][175][176][177]…”
Section: Pharmacodynamicsmentioning
confidence: 99%